# Memorial Sloan Kettering Cancer Center: Observational study closed enrollment, 1047 enrolled (Ovarian Cancer, Prostate Cancer)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Sponsor type | Academic and hospital |
| Study | Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes |
| NCT ID | NCT02917798 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Ovarian Cancer; Prostate Cancer; Pancreas Cancer |
| Intervention types | behavioral |
| Target enrollment | 1047 |
| Site countries | United States |
| Posted | 2016-09-28 |
| Planned start | 2016-07-12 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-05 |
| Last update posted | 2026-10-05 |

## Why this score
- Enrollment closed: data management, monitoring and closeout ahead.
- 1047 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT02917798). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.